JP2017201255A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017201255A5 JP2017201255A5 JP2016092898A JP2016092898A JP2017201255A5 JP 2017201255 A5 JP2017201255 A5 JP 2017201255A5 JP 2016092898 A JP2016092898 A JP 2016092898A JP 2016092898 A JP2016092898 A JP 2016092898A JP 2017201255 A5 JP2017201255 A5 JP 2017201255A5
- Authority
- JP
- Japan
- Prior art keywords
- marker
- level
- cancer
- subject
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003550 marker Substances 0.000 claims 16
- 201000011510 cancer Diseases 0.000 claims 11
- 102000018803 Calgranulin A Human genes 0.000 claims 6
- 108010052500 Calgranulin A Proteins 0.000 claims 6
- 210000004561 Lacrimal Apparatus Anatomy 0.000 claims 5
- 102100017879 S100A9 Human genes 0.000 claims 5
- 238000003018 immunoassay Methods 0.000 claims 5
- 206010006187 Breast cancer Diseases 0.000 claims 4
- 230000028327 secretion Effects 0.000 claims 4
- 102000004965 antibodies Human genes 0.000 claims 3
- 108090001123 antibodies Proteins 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 210000000481 Breast Anatomy 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 2
- 230000003247 decreasing Effects 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 239000012474 protein marker Substances 0.000 claims 2
- 108020004999 Messenger RNA Proteins 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000001809 detectable Effects 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000004811 liquid chromatography Methods 0.000 claims 1
- 238000004949 mass spectrometry Methods 0.000 claims 1
- 229920002106 messenger RNA Polymers 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
- 238000002331 protein detection Methods 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016092898A JP6755703B2 (ja) | 2016-05-05 | 2016-05-05 | がんの検出法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016092898A JP6755703B2 (ja) | 2016-05-05 | 2016-05-05 | がんの検出法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017201255A JP2017201255A (ja) | 2017-11-09 |
| JP2017201255A5 true JP2017201255A5 (es) | 2019-06-06 |
| JP6755703B2 JP6755703B2 (ja) | 2020-09-16 |
Family
ID=60265030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016092898A Active JP6755703B2 (ja) | 2016-05-05 | 2016-05-05 | がんの検出法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6755703B2 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111208229B (zh) * | 2020-01-17 | 2021-02-26 | 华中农业大学 | 蛋鸡低骨密度联合诊断血清代谢标志物的筛选方法及其应用 |
-
2016
- 2016-05-05 JP JP2016092898A patent/JP6755703B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Duijvesz et al. | Immuno‐based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer | |
| Wang et al. | Clinical significance of folate receptor-positive circulating tumor cells detected by ligand-targeted polymerase chain reaction in lung cancer | |
| Cai et al. | EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies | |
| JP2014144959A5 (es) | ||
| Wang et al. | Circulating miR‐210 as a diagnostic and prognostic biomarker for colorectal cancer | |
| Elemeery et al. | Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients | |
| WO2014140933A8 (en) | Method for the prognosis and treatment of cancer metastasis | |
| Chang et al. | Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection | |
| Szarvas et al. | Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer | |
| Murray et al. | A comparative performance analysis of total PSA, percentage free PSA, PSA velocity, and PSA density versus the detection of primary circulating prostate cells in predicting initial prostate biopsy findings in Chilean men | |
| Hoang et al. | A newly developed uroplakin II antibody with increased sensitivity in urothelial carcinoma of the bladder | |
| WO2014184679A3 (en) | Method for the prognosis and treatment of renal cell carcinoma metastasis | |
| Fatourou et al. | Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma | |
| NZ609824A (en) | Immunochromatography devices, methods and kits | |
| Yoo et al. | Highly dense, optically inactive silica microbeads for the isolation and identification of circulating tumor cells | |
| Li et al. | Noninvasive Diagnosis and Molecular Phenotyping of Breast Cancer through Microbead‐Assisted Flow Cytometry Detection of Tumor‐Derived Extracellular Vesicles | |
| JP2018511055A5 (es) | ||
| RU2019104870A (ru) | Комбинированный тест на наличие колоректального рака | |
| EA201391378A1 (ru) | Обнаружение биомаркеров в сложных биологических жидкостях с использованием библиотек и диагностических наборов на основе бусин или частиц и лекарственные средства | |
| JP2020514689A5 (es) | ||
| JP2016536568A5 (es) | ||
| WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
| Li et al. | Circulating tumor cell detection in epithelial ovarian cancer using dual-component antibodies targeting EpCAM and FRα | |
| JP2016212116A5 (es) | ||
| JP2017201255A5 (es) |